Rheonix Gets $12.6M in Series A Funding Round

The firm is developing an end-to-end molecular diagnostics system that it said could be used to automate new or existing assays using single or multiple raw clinical samples.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories